Mirae Asset Global Investments Co. Ltd. Raises Holdings in Axon Enterprise, Inc $AXON

Mirae Asset Global Investments Co. Ltd. increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 20.6% during the fourth quarter, Holdings Channel reports. The fund owned 41,450 shares of the biotechnology company’s stock after acquiring an additional 7,069 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Axon Enterprise were worth $23,541,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of AXON. Brighton Jones LLC acquired a new stake in Axon Enterprise during the fourth quarter worth approximately $480,000. NewEdge Advisors LLC boosted its position in Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after acquiring an additional 668 shares during the last quarter. Empowered Funds LLC boosted its position in Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after acquiring an additional 157 shares during the last quarter. Woodline Partners LP boosted its position in Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after acquiring an additional 2,003 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Axon Enterprise during the second quarter worth approximately $284,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,500 shares of Axon Enterprise stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the transaction, the chief accounting officer owned 12,240 shares in the company, valued at $7,019,028. This trade represents a 10.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 157 shares of Axon Enterprise stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at approximately $567,910. This trade represents a 11.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,855 shares of company stock worth $7,109,828 over the last 90 days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 2.5%

Shares of AXON opened at $402.85 on Friday. The firm has a market cap of $32.39 billion, a PE ratio of 265.03, a price-to-earnings-growth ratio of 8.39 and a beta of 1.61. The company’s fifty day moving average is $460.07 and its two-hundred day moving average is $554.07. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same quarter last year, the business earned $2.08 EPS. Analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on AXON shares. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Morgan Stanley restated an “overweight” rating on shares of Axon Enterprise in a research report on Wednesday, April 8th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Robert W. Baird set a $800.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Royal Bank Of Canada decreased their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $749.63.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.